Mergers & Acquisitions Mergers & Acquisitions

Illumina, EU Commission field hours of judges' questions to conclude long day’s appeal hearing

Illumina and the European Commission spent this afternoon fielding more than three hours of pointed questioning from the panel of judges considering the US biotech giant's appeal of the EU regulator's assertion of jurisdiction to review its buyout of cancer-test pioneer Grail. 

This morning, Illumina told the EU's General Court that the two

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Discover MLex

Stay on top of global regulatory developments

LEARN MORE LEARN MORE

Latest News